RBD-Modified Bacterial Vesicles Elicited Potential Protective Immunity against SARS-CoV-2

Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infection

(2021) Anastasia A Minervina et al.   eLife

Simultaneous CD8+ T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs

(2021) Flavia Ferrantelli et al.   Vaccines

A Hybrid Eukaryotic-Prokaryotic Nanoplatform with Photothermal Modality for Enhanced Antitumor Vaccination

(2020) Qi Chen et al.   ADVANCED MATERIALS

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

(2020) Alexandra C. Walls et al.   CELL

Immunostimulatory Potential of MoS2 Nanosheets: Enhancing Dendritic Cell Maturation, Migration and T Cell Elicitation

(2020) Lei Deng et al.   International Journal of Nanomedicine

Human neutralizing antibodies elicited by SARS-CoV-2 infection

(2020) Bin Ju et al.   NATURE

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

(2020) Jun Lan et al.   NATURE

A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

(2020) Lianpan Dai et al.   CELL

A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity

(2020) Jingyun Yang et al.   NATURE

Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles

(2020) Daning Wang et al.   Nature Communications

Engineering bacterial outer membrane vesicles as transdermal nanoplatforms for photo-TRAIL–programmed therapy against melanoma

(2020) Li-Hua Peng et al.   Science Advances

Synthetic Particles for Cancer Vaccines: Connecting the Inherent Supply Chain

(2020) Yufei Xia et al.   ACCOUNTS OF CHEMICAL RESEARCH

Biomineralized Bacterial Outer Membrane Vesicles Potentiate Safe and Efficient Tumor Microenvironment Reprogramming for Anticancer Therapy

(2020) Shuang Qing et al.   ADVANCED MATERIALS

Particulate Alum via Pickering Emulsion for an Enhanced COVID‐19 Vaccine Adjuvant

(2020) Sha Peng et al.   ADVANCED MATERIALS

Employing ATP as a New Adjuvant Promotes the Induction of Robust Antitumor Cellular Immunity by a PLGA Nanoparticle Vaccine

(2020) Qishu Zhang et al.   ACS Applied Materials & Interfaces

Bacterial Outer Membrane Vesicles Presenting Programmed Death 1 for Improved Cancer Immunotherapy via Immune Activation and Checkpoint Inhibition

(2020) Yao Li et al.   ACS Nano

Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19

(2020) Lauren B. Rodda et al.   CELL

T Cell Memory: Understanding COVID-19

(2020) Nicholas N. Jarjour et al.   IMMUNITY

Bioengineered bacterial vesicles as biological nano-heaters for optoacoustic imaging

(2019) Vipul Gujrati et al.   Nature Communications

Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8+ T cells

(2019) Sjoerd T.T. Schetters et al.   Acta Biomaterialia

Bacterium-Mimicking Vector with Enhanced Adjuvanticity for Cancer Immunotherapy and Minimized Toxicity

(2019) Binbin Zheng et al.   ADVANCED FUNCTIONAL MATERIALS

Bacterial Outer Membrane Vesicles (OMVs)-Based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV

(2019) Mahmoud M. Shehata et al.   Vaccines

Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8+ Lung-Resident Memory T Cells

(2019) Frances C. Knight et al.   ACS Nano

Development of novel nanoantibiotics using an outer membrane vesicle-based drug efflux mechanism

(2019) Weiwei Huang et al.   JOURNAL OF CONTROLLED RELEASE

Safe Staphylococcal Platform for the Development of Multivalent Nanoscale Vesicles against Viral Infections

(2018) Jizhen Yuan et al.   NANO LETTERS

Immunization with outer membrane vesicles displaying conserved surface polysaccharide antigen elicits broadly antimicrobial antibodies

(2018) Taylor C. Stevenson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Analysis of CD8+T cell response during the 2013–2016 Ebola epidemic in West Africa

(2018) Saori Sakabe et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection

(2017) Hannah C. Watkins et al.   MOLECULAR THERAPY

Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response

(2017) Oh Youn Kim et al.   Nature Communications

Biomimetically Engineered Demi-Bacteria Potentiate Vaccination against Cancer

(2017) Dezhi Ni et al.   Advanced Science

Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies

(2016) Linxiao Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Molecular basis for universal HLA-A*0201–restricted CD8+T-cell immunity against influenza viruses

(2016) Sophie A. Valkenburg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Modulating Antibacterial Immunity via Bacterial Membrane-Coated Nanoparticles

(2015) Weiwei Gao et al.   NANO LETTERS

Long-Term Efficacy of a Hepatitis E Vaccine

(2015) Jun Zhang et al.   NEW ENGLAND JOURNAL OF MEDICINE

The assembly dynamics of the cytolytic pore toxin ClyA

(2015) Stephan Benke et al.   Nature Communications

Bioengineered Bacterial Outer Membrane Vesicles as Cell-Specific Drug-Delivery Vehicles for Cancer Therapy

(2014) Vipul Gujrati et al.   ACS Nano

CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

(2011) Nancy J Sullivan et al.   NATURE MEDICINE

Differentiation of Effector CD4 T Cell Populations

(2010) Jinfang Zhu et al.   Annual Review of Immunology

The structure of a cytolytic α-helical toxin pore reveals its assembly mechanism

(2009) Marcus Mueller et al.   NATURE